Showing results (921-930 of 9,901) with videos related to

Sort By:
Pageof 991
Bone Marrow Transplantation|January 1, 1996
Bone marrow transplantation in a thalassemia patient with congenital heart diseaseD Baronciani, E Angelucci, F Agostinelli, et al.
Bone Marrow Transplantation|January 1, 1996
Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT)F Frassoni, M Labopin, E Gluckman, et al.
Bone Marrow Transplantation|January 1, 1996
A cell-saving non-radioactive limiting dilution analysis-assay for the combined determination of helper and cytotoxic T lymphocyte precursor frequenciesG J Bouma, U Schanz, M Oudshoorn, et al.
Bone Marrow Transplantation|January 1, 1996
Multi-organ dysfunction associated with high-dose carboplatin therapy prior to autologous transplantationA Grigg, J Szer, K Skov, et al.
Bone Marrow Transplantation|January 1, 1996
Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemiaC Rozman, E Carreras, C Qian, et al.
Bone Marrow Transplantation|January 1, 1996
Non-tunneled catheters in children undergoing bone marrow transplantationL Madero, D Ruano, M Villa, et al.
Bone Marrow Transplantation|April 1, 1995
Thrombocytopenia following autologous bone marrow transplantation: evidence for autoimmune aetiology and B cell clonal involvementM Sivakumaran, R M Hutchinson, H Pringle, et al.
Bone Marrow Transplantation|April 1, 1995
Graft-versus-leukemia in rat MHC-mismatched bone marrow transplantation is merely an allogeneic effectT C Kloosterman, A C Martens, D W van Bekkum, et al.
Bone Marrow Transplantation|April 1, 1995
Polyclonal Epstein-Barr virus-associated lymphoproliferative disorder following autografting for chronic myeloid leukemiaJ D Shepherd, R D Gascoyne, M J Barnett, et al.
Bone Marrow Transplantation|June 1, 1993
Local cutaneous reaction induced by subcutaneous interleukin-2 and interferon alpha-2a immunotherapy following ABMTL Klapholz, A Ackerstein, M A Goldenhersh, et al.
Pageof 991